Recurrent primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis after transplantation

Liver Transplantation

Volumn 7, Issue 11 SUPPL. 1, 2001, Pages s99-s108

  Faust, Thomas W ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERY OCCLUSION; ARTICLE; AUTOIMMUNE HEPATITIS; BILE DUCT INJURY; BILE DUCT OBSTRUCTION; BIOCHEMISTRY; BLOOD GROUP INCOMPATIBILITY; CHOLANGIOGRAPHY; CHRONICITY; CLINICAL FEATURE; CONTROLLED STUDY; DONOR; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEPATIC ARTERY; HISTOPATHOLOGY; HUMAN; LIVER TOXICITY; LIVER TRANSPLANTATION; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RECIPIENT; RECURRENT DISEASE; SEROLOGY; STANDARD; VIRUS HEPATITIS;

EID: 0035179042     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2001.28514     Document Type: Article

References (41)

1. Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2
2. Primary biliary cirrhosis
3. Recurrence of primary biliary cirrhosis after liver transplantation
4. Evidence for disease recurrence after liver transplantation for primary biliary cirrhosis. Clinical and histologic follow-up studies
5. Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation
6. Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation
7. Histological features predictive of recurrence of primary biliary cirrhosis after liver transplantation
8. Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis
9. Transplantation for primary biliary cirrhosis: Retrospective analysis of 400 patients in a single center
10. Recurrence of primary biliary cirrhosis after liver transplantation following FK506-based immunosuppression
11. Recurrence of primary biliary cirrhosis in the liver allograft: The effect of immunosuppression
12. Weaning of immunosuppression in liver transplant recipients
13. Subtypes of antimitochondrial antibodies in primary biliary cirrhosis before and after orthotopic liver transplantation
14. Antimitochondrial antibody profiles in patients with primary biliary cirrhosis before orthotopic liver transplantation and titres of antimitochondrial antibody-subtypes after transplantation
15. Pathologic analysis of liver transplantation for primary biliary cirrhosis
16. Transplantation for primary biliary cirrhosis
17. Persistence of gp210 and multiple nuclear dots antibodies does not correlate with recurrence of primary biliary cirrhosis 6 years after liver transplantation
18. Primary sclerosing cholangitis
19. Sclerosing cholangitis following human orthotopic liver transplantation
20. Fibrous and obliterative cholangitis in liver allografts: Evidence of recurrent primary sclerosing cholangitis?
21. Biliary strictures in hepatic transplants: Prevalence and types in patients with primary sclerosing cholangitis vs those with other liver diseases
22. Cholangiographic features of biliary strictures after liver transplantation for primary sclerosing cholangitis: Evidence of recurrent disease
23. Liver transplantation for sclerosing cholangitis
24. Recurrent primary sclerosing cholangitis after orthotopic liver transplantation
25. Recurrence of primary sclerosing cholangitis following liver transplantation
26. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis
27. Clinicopathologic findings of recurrent primary sclerosing cholangitis after orthotopic liver transplantation
28. Orthotopic liver transplantation for primary sclerosing cholangitis
29. Neutrophil cytoplasmic autoantibodies after liver transplantation in patients with primary sclerosing cholangitis
30. Autoimmune hepatitis
31. Recurrence of autoimmune chronic active hepatitis following orthotopic liver grafting
32. Disease recurrence and rejection following transplantation for autoimmune chronic active liver disease
33. Recurrence of autoimmune hepatitis in children after liver transplantation
34. Acute lobular hepatitis as the first manifestation of recurrent autoimmune hepatitis after orthotopic liver transplantation
35. Outcome of autoimmune hepatitis after liver transplantation
36. Liver transplantation for autoimmune hepatitis: Rejection and recurrence
37. Recurrence of autoimmune hepatitis after liver transplantation
38. Long-term follow-up after liver transplantation for autoimmune hepatitis: Evidence of recurrence of primary disease
39. Liver transplantation for autoimmune hepatitis
40. Liver transplantation for autoimmune hepatitis: A long-term pathologic study
41. Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis